Science ❯Biotechnology

Drug Development

Clinical Trials Oncology Smart Insulin Non-Pharmaceutical Interventions Cancer Therapies Therapeutic Candidates Biomacromolecules Integrated Stress Response Cancer Research Manufacturing Lifespan Extension Autoimmune Conditions ANAVEX®2-73 Phase 2 Studies Mechanism of Action Research and Development

Biontech Reports €700 Million Loss and Plans Workforce Restructuring

GSK Acquires US Biotech IDRx in $1.15 Billion Deal to Advance Rare Cancer Treatment

Breakthrough Drug Delivery System Crosses Blood-Brain Barrier

BioNTech Acquires China's Biotheus for $800 Million to Enhance Cancer Drug Development

Biontech's Revenue Surges with Updated Covid-19 Vaccine

New Nasal Spray Shows Promise in Blocking Multiple Respiratory Viruses

Moderna to Cut $1.1 Billion in R&D Spending as Vaccine Sales Decline

Summit Therapeutics' Lung Cancer Drug Outperforms Merck's Keytruda in Trial

Researchers Develop 'Smart Insulin' for Improved Diabetes Management

Biogen Acquires HI-Bio for $1.15 Billion to Enhance Immunology Pipeline

Loyal's Life-Extending Drug for Large Dogs Receives Conditional FDA Approval

Merck Acquires Prometheus Biosciences for $10 Billion Amid Keytruda Revenue Loss Fears